Honasa pivots from Mamaearth-only D2C to multi-brand FMCG play targeting HUL, P&G, Marico
Honasa Consumer is rebuilding offline distribution via Project Neev and scaling The Derma Co. (ARR >₹750 cr) after a Q2 FY25 net loss of ₹18.5 cr and a ~60% stock slide. FY31 goals: revenue >₹5,500 cr, Mamaearth ₹2,000 cr, The Derma Co. ₹1,500 cr+, EBITDA margin lifting to 15% from ~10%.
What happened
Mamaearth (Honasa Consumer) · Honasa Consumer is transforming from single-brand D2C player Mamaearth into a diversified FMCG portfolio to rival HUL, P&G and
Key facts
- Net loss ₹18.5 cr Q2 FY25 vs ₹29.4 cr profit YoY
- Revenue ₹461 cr vs ₹496 cr
- stock fell ~60% Sep-Nov 2024
- The Derma Co. ARR >₹750 cr
- FY31 revenue target >₹5,500 cr
- Mamaearth target ₹2,000 cr
- The Derma Co. target ₹1,500 cr+
- EBITDA margin target 15% from ~10%
- FY26 net profit ₹200 cr vs ₹72 cr
- share ₹468.55 on 6 July
Why this matters
Honasa's shift from single-brand D2C to a multi-brand FMCG portfolio directly targeting HUL, P&G, and Marico signals appetite for brand acquisitions and offline-distribution partnerships to hit its ₹5,500 cr FY31 revenue goal.
What to watch
- Q3/Q4 FY25 revenue return to YoY growth and gross margin trajectory
- Offline revenue mix % and distributor reach metrics under Project Neev
- The Derma Co. ARR crossing ₹1,000 cr milestone
- EBITDA margin movement toward mid-teens vs stalling near 10%
- Promoter/PE stake changes and any brand shutdowns or write-offs
- Accelerate Project Neev to correct channel inventory and rebuild distributor confidence post inventory-correction write-downs
- Prioritize The Derma Co. scaling given >₹750 cr ARR momentum as second growth engine
- Rationalize marketing spend, shifting from performance-heavy D2C acquisition to brand-building and offline pull
- Selectively acquire or incubate niche brands to fill FMCG adjacencies (haircare, color cosmetics)